Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

NCT00284154 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Small Cell
Lung Cancer

Interventions

DRUG: Vinflunine

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]